TSHA Taysha Gene Therapies, Inc.
$6.67
▼ 4.44%
43
Value
13
P/E-18.83
8
P/B11.54
40
P/S223.40
0
EV/EBITDA-10.81
5
Growth
54
Revenue Growth17.3%
72
EPS Growth5.6%
43
FCF Growth-15.0%
43
Momentum
88
12-Month Return233.5%
100
3-Month Return51.2%
100
1-Month Return46.6%
100
RSI (14)54.88
59
50/200 MABullish
75
Profitability
19
ROE-56.1%
40
ROA-43.2%
0
Gross Margin92.2%
73
Operating Margin-1774.4%
0
Net Margin-1738.4%
0
FCF Yield-6.7%
0
Risk
34
Beta1.23
75
60-Day Volatility77.4%
0
QScore Analysis